EMERYVILLE, Calif., July 22,
2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a
leading synthetic biotechnology company active in the Clean Health,
Beauty and Wellness markets through its consumer brands and a top
supplier of sustainable and natural ingredients, today announced a
partnership with Naomi Watts to
create a new consumer brand to provide science-backed, menopause
wellness personal care products. Ms. Watts, actress, mom and
co-founder of ONDA Beauty, has a personal commitment to clean
skincare, wellness and destigmatizing menopause.
By 2025, there will be over one billion people experiencing
menopause in the world, which will be 12% of the entire world
population of eight billion. Various symptoms and conditions are
experienced by approximately 75% of women and can lead to a
significant reduction in quality of life, increased utilization of
medical resources and an overall loss of productivity. Stigma, lack
of open discussion, and a very small product offering at an
affordable price contribute to a major barrier to care for
women.
With its Lab-to-Market™ science and technology,
Amyris is well positioned to lead the menopause market segment by
producing safe and sustainable ingredients for consumer products
with proven benefit to address menopausal concerns. This new brand
furthers Amyris' growth and market leadership to provide clean
health, beauty and wellness to consumers of all life stages and
complements Amyris' family of leading consumer brands.
"The shame and lack of community surrounding menopause has made
me feel alone, confused and overwhelmed. The belief that menopause
means a woman's time is up is ludicrous and should not exist," said
Ms. Watts. "In partnering with Amyris, we're endeavoring to equip
all phases of menopause with products, tools and resources that
make us feel celebrated and empowered, both physically and
emotionally. No one should walk through this alone. I couldn't be
more excited and proud to share what we've been working on together
very soon."
"We are pleased to welcome Naomi
Watts to the Amyris family of brands and join her in
destigmatizing menopause and supporting women's health," said
John Melo, President and CEO of
Amyris. "Naomi shares our vision for a more sustainable future and
we look forward to launching this brand in 2022 as part of our
ongoing effort to create, manufacture and market clean, healthy and
effective products for all."
About Amyris
Amyris (Nasdaq: AMRS) is a science and
technology leader in the research, development and production of
sustainable ingredients for the Clean Health & Beauty and
Flavors & Fragrances markets. Amyris uses an impressive array
of exclusive technologies, including state-of-the-art machine
learning, robotics and artificial intelligence. Our ingredients are
included in over 20,000 products from the world's top brands,
reaching more than 300 million consumers. Amyris is proud to own
and operate a family of consumer brands - all built around its No
Compromise® promise of clean ingredients: Biossance® clean beauty
skincare, Pipette® clean baby skincare, and Purecane™, a
zero-calorie sweetener naturally derived from sugarcane. For more
information, please visit http://www.amyris.com.
Forward-Looking Statements
This release
contains forward-looking statements, and any statements other than
statements of historical fact could be deemed to be forward-looking
statements. These forward-looking statements include, among other
things, statements regarding Amyris' expectation of furthering its
growth and market leadership in clean health, beauty and wellness
and leading the sector in menopause products; Amyris' plans to
launch a menopause-focused brand and the timing thereof; and
Amyris' expectations regarding launches of new brands. These
statements are based on management's current expectations and
actual results and future events may differ materially due to risks
and uncertainties, including risks related to any delays or
failures in the successful launch of a menopause-focused
brand; potential delays or failures in development,
production, regulatory approval and commercialization of products,
risks related to Amyris' reliance on third parties (including in
the supply chain); Amyris' liquidity and ability to fund operating
and capital expenses; and other risks detailed from time to time in
filings Amyris makes with the Securities and Exchange Commission,
including Annual Reports on Form 10-K, Quarterly Reports on Form
10-Q and Current Reports on Form 8-K. Amyris disclaims any
obligation to update information contained in these forward-looking
statements, whether as a result of new information, future events,
or otherwise.
Amyris, the Amyris logo, No Compromise, Biossance, Pipette, and
Purecane are trademarks or registered trademarks of Amyris, Inc. in
the U.S. and/or other countries.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/amyris-partners-with-naomi-watts-to-launch-science-backed-wellness-brand-focused-on-menopause-301339385.html
SOURCE Amyris, Inc.